Luyan Pharma Co Ltd
Luyan Pharma Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products in China. The company distributes medicines, Chinese herbal medicines, medical devices, and others; and provides medical care, elderly care, and wellness services. It also operates pharmaceutical retail chains. The company was formerly known as Luyan (Fujian… Read more
Market Cap & Net Worth: Luyan Pharma Co Ltd (002788)
Luyan Pharma Co Ltd (SHE:002788) has a market capitalization of $752.44 Million (CN¥5.52 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #10779 globally and #2435 in its home market, demonstrating a -4.05% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Luyan Pharma Co Ltd's stock price CN¥14.21 by its total outstanding shares 388516736 (388.52 Million).
Luyan Pharma Co Ltd Market Cap History: 2016 to 2026
Luyan Pharma Co Ltd's market capitalization history from 2016 to 2026. Data shows growth from $958.11 Million to $752.44 Million (5.60% CAGR).
Luyan Pharma Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Luyan Pharma Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Luyan Pharma Co Ltd's market cap is 0.02 times its annual revenue
7.95x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
1.26x
Luyan Pharma Co Ltd's market cap is 1.26 times its annual earnings
1.77x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $958.11 Million | $6.98 Billion | $115.52 Million | 0.14x | 8.29x |
| 2017 | $484.58 Million | $8.34 Billion | $130.58 Million | 0.06x | 3.71x |
| 2018 | $311.24 Million | $11.50 Billion | $180.32 Million | 0.03x | 1.73x |
| 2019 | $346.15 Million | $15.01 Billion | $255.89 Million | 0.02x | 1.35x |
| 2020 | $368.48 Million | $15.53 Billion | $266.63 Million | 0.02x | 1.38x |
| 2021 | $371.60 Million | $17.55 Billion | $305.87 Million | 0.02x | 1.21x |
| 2022 | $410.91 Million | $19.46 Billion | $345.16 Million | 0.02x | 1.19x |
| 2023 | $458.20 Million | $19.85 Billion | $363.53 Million | 0.02x | 1.26x |
| 2024 | $434.73 Million | $20.47 Billion | $345.64 Million | 0.02x | 1.26x |
Competitor Companies of 002788 by Market Capitalization
Companies near Luyan Pharma Co Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Luyan Pharma Co Ltd by market ranking:
- Alibaba Health Information Technology Limited (PINK:ALBBY): Ranked #1435 globally with a market cap of $12.50 Billion USD.
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #1880 globally with a market cap of $8.58 Billion USD.
- Raia Drogasil S.A (SA:RADL3): Ranked #2749 globally with a market cap of $5.08 Billion USD ( R$30.91 Billion BRL).
- Clicks Group Ltd (PINK:CLCGY): Ranked #2859 globally with a market cap of $4.80 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1435 | Alibaba Health Information Technology Limited | PINK:ALBBY | $12.50 Billion | $12.32 |
| #1880 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $8.58 Billion | $11.98 |
| #2749 | Raia Drogasil S.A | SA:RADL3 | $5.08 Billion | R$23.58 |
| #2859 | Clicks Group Ltd | PINK:CLCGY | $4.80 Billion | $35.11 |
Luyan Pharma Co Ltd Historical Marketcap From 2016 to 2026
Between 2016 and today, Luyan Pharma Co Ltd's market cap moved from $958.11 Million to $ 752.44 Million, with a yearly change of 5.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥752.44 Million | -32.91% |
| 2025 | CN¥1.12 Billion | +157.98% |
| 2024 | CN¥434.73 Million | -5.12% |
| 2023 | CN¥458.20 Million | +11.51% |
| 2022 | CN¥410.91 Million | +10.58% |
| 2021 | CN¥371.60 Million | +0.85% |
| 2020 | CN¥368.48 Million | +6.45% |
| 2019 | CN¥346.15 Million | +11.22% |
| 2018 | CN¥311.24 Million | -35.77% |
| 2017 | CN¥484.58 Million | -49.42% |
| 2016 | CN¥958.11 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Luyan Pharma Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $752.44 Million USD |
| MoneyControl | $752.44 Million USD |
| MarketWatch | $752.44 Million USD |
| marketcap.company | $752.44 Million USD |
| Reuters | $752.44 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.